Shanghai ZJ Bio-Tech Co. Ltd. A Working Capital to Net Assets Ratio
Shanghai ZJ Bio-Tech Co. Ltd. A working capital to net assets ratio. Shanghai ZJ Bio-Tech Co. Ltd. A (688317) has a Working Capital to Net Assets ratio of 84.8% as of June 2026. Working capital of CN¥2.76 Billion (current assets of CN¥2.88 Billion minus current liabilities of CN¥113.37 Million) is measured against net assets of CN¥3.26 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Shanghai ZJ Bio-Tech Co. Ltd. A (688317) tangible equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Shanghai ZJ Bio-Tech Co. Ltd. A (2013–2025)
Working capital to net assets ratio of Shanghai ZJ Bio-Tech Co. Ltd. A from 2013 to 2025. This chart shows how Shanghai ZJ Bio-Tech Co. Ltd. A's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2013 to 2025. As of June 2026, the ratio stands at 84.8%, reflecting working capital of CN¥2.76 Billion against net assets of CN¥3.26 Billion CNY. See how many days can Shanghai ZJ Bio-Tech Co. Ltd. A fund operations to measure how many days the company can operate on defensive assets alone.
Shanghai ZJ Bio-Tech Co. Ltd. A Working Capital to Net Assets Ratio by Year (2013–2025)
Shanghai ZJ Bio-Tech Co. Ltd. A working capital to net assets ratio by year from 2013 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Shanghai ZJ Bio-Tech Co. Ltd. A from 2013 to 2025, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Shanghai ZJ Bio-Tech Co. Ltd. A (688317) total assets.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 85.4% | CN¥2.86 Billion | CN¥3.35 Billion | CN¥2.99 Billion | CN¥126.58 Million | ▲ +8.7 pp |
| 2024 | 76.7% | CN¥2.79 Billion | CN¥3.64 Billion | CN¥2.94 Billion | CN¥145.99 Million | ▲ +0.1 pp |
| 2023 | 76.6% | CN¥2.93 Billion | CN¥3.82 Billion | CN¥3.17 Billion | CN¥236.56 Million | ▼ -4.0 pp |
| 2022 | 80.6% | CN¥3.39 Billion | CN¥4.20 Billion | CN¥3.91 Billion | CN¥523.86 Million | ▼ -1.5 pp |
| 2021 | 82.1% | CN¥3.14 Billion | CN¥3.83 Billion | CN¥3.55 Billion | CN¥409.00 Million | ▲ +0.3 pp |
| 2020 | 81.9% | CN¥1.20 Billion | CN¥1.46 Billion | CN¥1.58 Billion | CN¥385.39 Million | ▲ +21.2 pp |
| 2019 | 60.6% | CN¥346.70 Million | CN¥571.84 Million | CN¥403.67 Million | CN¥56.97 Million | ▼ -7.5 pp |
| 2018 | 68.1% | CN¥362.91 Million | CN¥532.66 Million | CN¥405.15 Million | CN¥42.24 Million | ▲ +2.9 pp |
| 2017 | 65.3% | CN¥308.50 Million | CN¥472.70 Million | CN¥342.51 Million | CN¥34.00 Million | ▼ -1.2 pp |
| 2016 | 66.5% | CN¥321.56 Million | CN¥483.90 Million | CN¥354.03 Million | CN¥32.46 Million | ▼ -6.5 pp |
| 2015 | 72.9% | CN¥250.53 Million | CN¥343.47 Million | CN¥291.16 Million | CN¥40.63 Million | ▲ +40.1 pp |
| 2014 | 32.8% | CN¥36.20 Million | CN¥110.35 Million | CN¥106.26 Million | CN¥70.06 Million | ▼ -17.0 pp |
| 2013 | 49.8% | CN¥58.76 Million | CN¥118.03 Million | CN¥82.30 Million | CN¥23.53 Million | — |